Summit Therapeutics Statistics
NASDAQ: SMMTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.17-0.78 (-4.35%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 17.44 +1.57%
Summit Therapeutics by the numbers
Summit Therapeutics has a market capitalization of $13.70 billion based on 797.75M shares outstanding. With trailing EPS of $-1.11, Summit Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.6% above its 50-day average and 5.0% above its 200-day average.
Average daily trading volume is 5.82M shares, or about $99.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SMMT valuation vs. peer median
| Metric | SMMT | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.70B | $11.99B | +14% |
| Avg. volume | 5.82M | 1.67M | +249% |
Peer median across 8 companies: JAZZ, CORT, ASND, BBIO, ELAN, MDGL, BMRN, RDY.
Valuation
- Market cap
- $13.70B
- EPS (TTM)
- $-1.11
- Shares outstanding
- 797.75M
Price and trading
- Previous close
- 17.95
- Open
- 17.61
- Day range
- 16.80 – 17.64
- 52-week range
- 12.07 – 29.23
- 52-week change
- -26.44%
- Beta
- —
- Volume
- 6.17M
- Average volume
- 5.82M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 19, 2026
Additional statistics
- Market Cap
- 13.70B
- Forward Pe
- -15.07
- Eps
- -1.11
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 29.23
- Week52 Low
- 12.07
- Avg Volume
- 5.82M
- Shares Outstanding
- 797.75M
- Ma50
- 15.38
- Ma200
- 16.36
- Earnings Date
- Oct 19, 2026
- Pct From52w High
- -41.26%
- Pct From52w Low
- 42.25%